{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:34:10Z","timestamp":1769834050673,"version":"3.49.0"},"reference-count":69,"publisher":"Edizioni Minerva Medica","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Panminerva Med"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.23736\/s0031-0808.20.04146-4","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T08:48:59Z","timestamp":1612514939000},"source":"Crossref","is-referenced-by-count":3,"title":["CAR T cells targeting options in the fight against multiple myeloma"],"prefix":"10.23736","volume":"63","author":[{"given":"Fabio","family":"NICOLINI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"BRAVACCINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"MAZZA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja M.","family":"GRUSZKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"TAZZARI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"MART\u00cdN-ANTONIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"JUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"IBRAHIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"MALTONI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"MARTINELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"CERCHIONE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17149","reference":[{"key":"10.23736\/S0031-0808.20.04146-4_ref001","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.46"},{"key":"10.23736\/S0031-0808.20.04146-4_ref002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-493361"},{"key":"10.23736\/S0031-0808.20.04146-4_ref003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442"},{"key":"10.23736\/S0031-0808.20.04146-4_ref004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-358812"},{"key":"10.23736\/S0031-0808.20.04146-4_ref005","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.63"},{"key":"10.23736\/S0031-0808.20.04146-4_ref006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226"},{"key":"10.23736\/S0031-0808.20.04146-4_ref007","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01821"},{"key":"10.23736\/S0031-0808.20.04146-4_ref008","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031330"},{"key":"10.23736\/S0031-0808.20.04146-4_ref009","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.001"},{"key":"10.23736\/S0031-0808.20.04146-4_ref010","first-page":"37","article-title":"Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy, in R\/R multiple myeloma (MM) patients: updated results of a first-in-human (FIH) phase I dose escalation study","author":"Topp MS","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.23736\/S0031-0808.20.04146-4_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30576-X"},{"key":"10.23736\/S0031-0808.20.04146-4_ref012","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0669-4"},{"key":"10.23736\/S0031-0808.20.04146-4_ref013","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21596"},{"key":"10.23736\/S0031-0808.20.04146-4_ref014","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126397"},{"key":"10.23736\/S0031-0808.20.04146-4_ref015","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0681-6"},{"key":"10.23736\/S0031-0808.20.04146-4_ref016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113548"},{"key":"10.23736\/S0031-0808.20.04146-4_ref017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111576"},{"key":"10.23736\/S0031-0808.20.04146-4_ref018","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129562"},{"key":"10.23736\/S0031-0808.20.04146-4_ref019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116953"},{"key":"10.23736\/S0031-0808.20.04146-4_ref020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126660"},{"key":"10.23736\/S0031-0808.20.04146-4_ref021","first-page":"38","article-title":"Update of CARTITUDE-1: A phase Ib\/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed\/refractory multiple myeloma","author":"Berdeja JG","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.23736\/S0031-0808.20.04146-4_ref022","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2510"},{"key":"10.23736\/S0031-0808.20.04146-4_ref023","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4246"},{"key":"10.23736\/S0031-0808.20.04146-4_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00197-0"},{"key":"10.23736\/S0031-0808.20.04146-4_ref025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505654"},{"key":"10.23736\/S0031-0808.20.04146-4_ref026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-778423"},{"key":"10.23736\/S0031-0808.20.04146-4_ref027","doi-asserted-by":"publisher","DOI":"10.1309\/617DWB5GNFWXHW4L"},{"key":"10.23736\/S0031-0808.20.04146-4_ref028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761643"},{"key":"10.23736\/S0031-0808.20.04146-4_ref029","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1545"},{"key":"10.23736\/S0031-0808.20.04146-4_ref030","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26792"},{"key":"10.23736\/S0031-0808.20.04146-4_ref031","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290012146"},{"key":"10.23736\/S0031-0808.20.04146-4_ref032","doi-asserted-by":"publisher","DOI":"10.1126\/science.1373518"},{"key":"10.23736\/S0031-0808.20.04146-4_ref033","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4120"},{"key":"10.23736\/S0031-0808.20.04146-4_ref034","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-3096"},{"key":"10.23736\/S0031-0808.20.04146-4_ref035","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.12.002"},{"key":"10.23736\/S0031-0808.20.04146-4_ref036","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120505"},{"key":"10.23736\/S0031-0808.20.04146-4_ref037","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504542"},{"key":"10.23736\/S0031-0808.20.04146-4_ref038","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10948-w"},{"key":"10.23736\/S0031-0808.20.04146-4_ref039","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00093-X"},{"key":"10.23736\/S0031-0808.20.04146-4_ref040","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"10.23736\/S0031-0808.20.04146-4_ref041","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02722"},{"key":"10.23736\/S0031-0808.20.04146-4_ref042","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.137620"},{"key":"10.23736\/S0031-0808.20.04146-4_ref043","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1004"},{"key":"10.23736\/S0031-0808.20.04146-4_ref044","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00097"},{"key":"10.23736\/S0031-0808.20.04146-4_ref045","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1016\/S0021-9258(18)37632-4","article-title":"A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats","volume":"263","author":"Gendler S","year":"1988","journal-title":"J Biol Chem"},{"key":"10.23736\/S0031-0808.20.04146-4_ref046","doi-asserted-by":"crossref","first-page":"15286","DOI":"10.1016\/S0021-9258(18)77254-2","article-title":"Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin","volume":"265","author":"Gendler SJ","year":"1990","journal-title":"J Biol Chem"},{"key":"10.23736\/S0031-0808.20.04146-4_ref047","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.26.18165"},{"key":"10.23736\/S0031-0808.20.04146-4_ref048","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800445"},{"key":"10.23736\/S0031-0808.20.04146-4_ref049","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-659151"},{"key":"10.23736\/S0031-0808.20.04146-4_ref050","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14801"},{"key":"10.23736\/S0031-0808.20.04146-4_ref051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"10.23736\/S0031-0808.20.04146-4_ref052","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86000"},{"key":"10.23736\/S0031-0808.20.04146-4_ref053","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2010.21"},{"key":"10.23736\/S0031-0808.20.04146-4_ref054","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504312102"},{"key":"10.23736\/S0031-0808.20.04146-4_ref055","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5335.138"},{"key":"10.23736\/S0031-0808.20.04146-4_ref056","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005224200"},{"key":"10.23736\/S0031-0808.20.04146-4_ref057","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781351"},{"key":"10.23736\/S0031-0808.20.04146-4_ref058","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126689"},{"key":"10.23736\/S0031-0808.20.04146-4_ref059","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000703"},{"key":"10.23736\/S0031-0808.20.04146-4_ref060","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.2.377.377"},{"key":"10.23736\/S0031-0808.20.04146-4_ref061","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01134.x"},{"key":"10.23736\/S0031-0808.20.04146-4_ref062","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.6.2233"},{"key":"10.23736\/S0031-0808.20.04146-4_ref063","first-page":"72","article-title":"Abstract 3499: CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma","author":"Benjamin R","year":"2012","journal-title":"Cancer Res"},{"key":"10.23736\/S0031-0808.20.04146-4_ref064","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.036814"},{"key":"10.23736\/S0031-0808.20.04146-4_ref065","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1046658"},{"key":"10.23736\/S0031-0808.20.04146-4_ref066","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2012.02679.x"},{"key":"10.23736\/S0031-0808.20.04146-4_ref067","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau7746"},{"key":"10.23736\/S0031-0808.20.04146-4_ref068","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.03.016"},{"key":"10.23736\/S0031-0808.20.04146-4_ref069","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8503"}],"container-title":["Panminerva Medica"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R41Y2021N01A0037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T08:50:11Z","timestamp":1612515011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R41Y2021N01A0037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":69,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.23736\/s0031-0808.20.04146-4","relation":{},"ISSN":["0031-0808","1827-1898"],"issn-type":[{"value":"0031-0808","type":"print"},{"value":"1827-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}